These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 3107969
21. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin. Ganey PE, Sprugel KH, Hadley KB, Roth RA. J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908 [Abstract] [Full Text] [Related]
23. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole. Ganey PE, Roth RA. Am J Physiol; 1987 Apr; 252(4 Pt 2):H743-8. PubMed ID: 2952022 [Abstract] [Full Text] [Related]
24. Imbalance between plasma levels of thromboxane B2 and 6-keto-prostaglandin F1 alpha during subacute endotoxin-induced hyperdynamic sepsis or multiple organ failure syndrome in sheep. Pittet JF, Morel DR. Circ Shock; 1991 Oct; 35(2):65-77. PubMed ID: 1777948 [Abstract] [Full Text] [Related]
25. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2. Ylikorkala O, Mäkilä UM, Viinikka L. Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904 [Abstract] [Full Text] [Related]
26. Leukotriene F4 and the release of arachidonic acid metabolites from perfused guinea pig lungs in vitro. Lord A, Charleson S, Letts LG. Prostaglandins; 1985 Apr; 29(4):651-60. PubMed ID: 3923570 [Abstract] [Full Text] [Related]
27. Cyclooxygenase products from endogenous arachidonic acid in isolated dog and rabbit lungs. Littner MR, Lott FD. Am Rev Respir Dis; 1988 Aug; 138(2):383-8. PubMed ID: 3143287 [Abstract] [Full Text] [Related]
28. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity. Bruner LH, Bull RW, Roth RA. Toxicol Appl Pharmacol; 1987 Oct; 91(1):1-12. PubMed ID: 3672514 [Abstract] [Full Text] [Related]
29. C3a57-77, a C-terminal peptide, causes thromboxane-dependent pulmonary vascular constriction in isolated perfused rat lungs. Morganroth ML, Schoeneich SO, Till GO, Ward PA, Horvath SJ, Glovsky MM. Am Rev Respir Dis; 1990 Feb; 141(2):296-300. PubMed ID: 2105683 [Abstract] [Full Text] [Related]
30. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. Chiabrando C, Pinciroli V, Campoleoni A, Benigni A, Piccinelli A, Fanelli R. J Chromatogr; 1989 Oct 27; 495():1-11. PubMed ID: 2613794 [Abstract] [Full Text] [Related]
31. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects. Chiabrando C, Rivoltella L, Martelli L, Valzacchi S, Fanelli R. Biochim Biophys Acta; 1992 Feb 03; 1133(3):247-54. PubMed ID: 1737057 [Abstract] [Full Text] [Related]
32. Effects of imidazole and indomethacin on fluid balance in isolated sheep lungs. Patterson GA, Rock P, Mitzner WA, Adkinson NF, Sylvester JT. J Appl Physiol (1985); 1985 Mar 03; 58(3):892-8. PubMed ID: 3884582 [Abstract] [Full Text] [Related]
33. Altered aortic production of 6-keto-prostaglandin F1 alpha from aldosterone-salt hypertensive rats. Jones SB, Liu Y, Jones AW. J Vasc Res; 1992 Mar 03; 29(3):256-63. PubMed ID: 1504198 [Abstract] [Full Text] [Related]
34. Release of von Willebrand factor antigen (vWF:Ag) and eicosanoids during acute injury to the isolated rat lung. Jones DK, Perry EM, Grosso MA, Voelkel NF. Am Rev Respir Dis; 1992 Jun 03; 145(6):1410-5. PubMed ID: 1596010 [Abstract] [Full Text] [Related]
36. [The changes of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1 alpha(6-keto-PGF1 alpha) in the lungs of rats drowned in hypothermic-sea-water]. Jiang Z, Zhong G, Wang EE, Fan J, Jia G, Lu Q, Yang D. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Feb 03; 20(1):29-31. PubMed ID: 14694611 [Abstract] [Full Text] [Related]
37. Arterial 6-keto-PGF1 alpha and TxB2 release in ex vivo perfused canine vessels: effects of pulserate, pulsatility, altered pressure and flow rate. Brunkwall JS, Stanley JC, Graham LM, Burkel WE, Bergqvist D. Eur J Vasc Surg; 1989 Jun 03; 3(3):219-25. PubMed ID: 2501107 [Abstract] [Full Text] [Related]
38. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia. Ganey PE, Sprugel KH, White SM, Wagner JG, Roth RA. Am J Physiol; 1988 Nov 03; 255(5 Pt 2):H1165-72. PubMed ID: 3189578 [Abstract] [Full Text] [Related]
39. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole. Schultze AE, Emeis JJ, Roth RA. Biochem Pharmacol; 1996 Jan 26; 51(2):187-91. PubMed ID: 8615888 [Abstract] [Full Text] [Related]
40. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor. Carter AJ, Bevan JA, Hanley SP, Morgan WE, Turner DR. Thromb Haemost; 1984 Apr 30; 51(2):257-60. PubMed ID: 6377567 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]